Spire Wealth Management Matinas Bio Pharma Holdings, Inc. Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$0.5 - $1.06 $80,580 - $170,829	-161,160 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$0.92 - $1.22 $145,507 - $192,955	158,160 Added 5272.0%	161,160 $163,000
Q3 2021 Oct 22, 2021	BUY	$0.67 - $1.51 $2,010 - $4,530	3,000 New	3,000 $4,000
Q2 2021 Jul 26, 2021	SELL	$0.75 - $1.1 $197,370 - $289,476	-263,160 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$0.96 - $1.74 $213,273 - $386,558	222,160 Added 541.85%	263,160 $292,000
Q1 2021 May 07, 2021	BUY	$0.96 - $1.74 $39,360 - $71,340	41,000 New	41,000 $43,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.